AVE 33.3% 0.2¢ avecho biotechnology limited

esra ogru background, page-64

  1. 5,322 Posts.
    Would seem the support continues today Turps. Might we see some more interest in POH if single dose ann comes through and surprises resultswise. POH is still a Biotech with emerging pipeline still intact despite the CEO debacle and negative press coverage. Hope the punters can see past the actions of a greedy staffer and rate the company on progress not scandal.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.